Logo image of HUMA

HUMACYTE INC (HUMA) Stock Analyst Earnings Estimates

NASDAQ:HUMA - Nasdaq - US44486Q1031 - Common Stock - Currency: USD

3.06  -0.34 (-10%)

Premarket: 3.08 +0.02 (+0.65%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
HUMA revenue by date.HUMA revenue by date.
1.49M
-75.93%
1.26M
-15.44%
1.57M
24.60%
58.283K
-100.00%
218.576K9.715M
4,344.68%
120.7M
1,142.41%
284.54M
135.74%
513.68M
80.53%
716.34M
39.45%
1.161B
62.07%
2.463B
112.14%
3.006B
22.05%
EBITDA
YoY % growth
HUMA ebitda by date.HUMA ebitda by date.
-56.25M
28.74%
-72.96M
-29.71%
-76.37M
-4.67%
-98.634M
-20.90%
-83.232M
9.85%
-60.486M
27.33%
714K
101.18%
12.75M
1,685.71%
68.952M
440.80%
130.25M
88.90%
212.47M
63.12%
308.04M
44.98%
N/A
EBIT
YoY % growth
HUMA ebit by date.HUMA ebit by date.
-64.6M
24.61%
-81.2M
-25.70%
-84.58M
-4.16%
-100.904M
-18.29%
-118.406M
-18.35%
-113.578M
4.08%
-23.943M
78.92%
139.01M
680.58%
401.86M
189.09%
610.47M
51.91%
865.38M
41.76%
2.243B
159.19%
2.863B
27.64%
Operating Margin
HUMA operating margin by date.HUMA operating margin by date.
-4,335.57%-6,444.44%-5,387.26%-173,128.65%-54,171.38%-1,169.10%-19.84%48.85%78.23%85.22%74.54%91.07%95.24%
EPS
YoY % growth
HUMA eps by date.HUMA eps by date.
N/A-0.51-0.13
74.51%
-1.08
-723.08%
-1.33
-24.33%
-0.88
33.63%
-0.22
75.55%
0.85
493.68%
2.67
214.41%
3.86
44.47%
5.46
41.48%
9.70
77.50%
11.51
18.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.26
-9.08%
-0.24
15.59%
-0.24
50.06%
-0.24
25.82%
-0.24
7.47%
Revenue
Q2Q % growth
218.576K816K1.499M2.326M3.32M
1,418.92%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-30.483M
-16.43%
-30.708M
-15.54%
-30.288M
-2.67%
-30.942M
-2.34%
-30.742M
-0.85%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.33
-32.00%
-0.25-0.08-30.16%
Q2 2024
Q2Q % growth
-0.48
-118.18%
-0.24-0.24-97.73%
Q1 2024
Q2Q % growth
-0.29
19.44%
-0.23-0.06-26.36%
Q4 2023
Q2Q % growth
-0.24
-500.00%
-0.250.013.91%
Q3 2023
Q2Q % growth
-0.25 -0.260.013.25%
Q2 2023
Q2Q % growth
-0.22
-162.86%
-0.220.001.81%
Q1 2023
Q2Q % growth
-0.36
-89.47%
-0.21-0.15-68.39%
Q4 2022
Q2Q % growth
-0.04
-109.76%
-0.240.2083.31%
Q3 2022
Q2Q % growth
-0.25
65.28%
-0.22-0.03-14.00%
Q2 2022
Q2Q % growth
0.35 -0.220.57257.16%
Q1 2022
Q2Q % growth
-0.19
5.00%
-0.210.029.87%
Q4 2021
Q2Q % growth
0.41 -0.210.62296.08%
Q3 2021
Q2Q % growth
-0.72 -0.21-0.51-243.78%
Q2 2021
Q2Q % growth
0.00 -0.580.58100.00%
Q1 2021
Q2Q % growth
-0.20 -0.920.7278.21%
HUMA Yearly EPS VS EstimatesHUMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth
58.283K-58.283K-100.00%
Q3 2023
Q2Q % growth

-100.00%
68.003K-68.003K-100.00%
Q2 2023
Q2Q % growth

-100.00%
68.003K-68.003K-100.00%
Q1 2023
Q2Q % growth

-100.00%
168.912K-168.912K-100.00%
Q4 2022
Q2Q % growth

-100.00%
200.093K-200.093K-100.00%
Q3 2022
Q2Q % growth
30K
-87.50%
207.57K-177.57K-85.55%
Q2 2022
Q2Q % growth
1.3M
88.41%
208.59K1.091M523.23%
Q1 2022
Q2Q % growth
230K
43.75%
250.308K-20.308K-8.11%
Q4 2021
Q2Q % growth
180K
50.00%
259.08K-79.08K-30.52%
Q3 2021
Q2Q % growth
240K
-73.63%
379.103K-139.103K-36.69%
Q2 2021
Q2Q % growth
690K 102K588K576.47%
HUMA Yearly Revenue VS EstimatesHUMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.08% 0% 3.59%
Revenue0% 0% 0% 0%